Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects

NCT ID: NCT05640141

Last Updated: 2022-12-07

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 160 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2022-01-26
• Study Completion Date: 2024-12-30

Brief Summary

The main aim of the study is to characterize and understand the pathological mechanisms underlying the motoric cognitive risk syndrome, which is a predictor of Alzheimer disease.

Detailed Description

Alzheimer's disease (AD) is affecting more than 46.8 million people worldwide, making dementia one of the greatest public health challenges of the 21st century. The progression of AD is slow with a presymptomatic course over several years to decades, during which pathophysiological changes are underway, but the disease has not yet caused any noticeable symptoms to warrant a clinical diagnosis. A strong effort is ongoing to identify biomarkers preceding cognitive decline that can aid diagnosis and early intervention. Criteria for the motoric cognitive risk syndrome (MCR), including subjective cognitive decline (SCD) and slower preferred walking speed, but otherwise normal functioning, are powerful risk indicators of developing cognitive impairment and dementia. The presence of MCR is associated with a more than three-fold risk of developing dementia while the risk is only two-fold for SCD or slow gait alone. However, the pathophysiology of MCR is unknown and getting into the processes that cause such condition is needed to complement the MCR-based criteria and increase their predictive validity of cognitive decline and dementia. Impaired attentional control related to white matter alterations of presumed vascular origin may be responsible for the MCR phenotype. Individuals with SCD exhibit loss of white matter integrity in brain regions typically involved in attentional control, and abnormally slow gait has been linked to the disruption of white matter tracts associated with executive attention. Furthermore, a deeper understanding of MCR requires considering not only regional white matter changes but also the individuals' cognitive capacity to cope with brain damages, namely the cognitive reserve. Hence, the PRESAGE project intends to evaluate the interplay of white matter integrity and cognitive reserve on attentional control in MCR and non-MCR individuals aged 60 or older. Attentional control will be explored at both the behavioral and brain levels using dual-task challenges where individuals will have to divide attention between a cognitive (stroop) task and a motor task (walking). The working hypothesis is that the dual-task cost - a proxy of attentional control - is predictive of white matter abnormalities which, when adjusted for cognitive reserve, age and sex, should discriminate between MCR and non-MCR individuals. The project also includes a prospective, longitudinal study (two-year follow-up) whose purpose is to determine whether this marker, alone or in combination with other potentially relevant markers (i.e., neuropsychological, functional and chronobiological), have predictive value for conversion from MCR to mild cognitive impairment and dementia. Findings will increase knowledge about the pathophysiology of MCR and will contribute to improve MCR criteria and early identification of at-risk individuals.

Conditions

Motoric Cognitive Risk Syndrome; Mild Cognitive Impairment; Alzheimer Disease; Dementia

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Control

Control group composed of 80 healthy aged volunteers.

MRI evaluation

Intervention Type: PROCEDURE

Multimodal MRI evaluation :

• T1 structural,
• Resting echo planar imaging
• Diffusion-weighted imaging
• Arterial sping labeling
• Fluid-attenuated inversion recovery

Actimetry & IMU

Intervention Type: BEHAVIORAL

Evaluation of daily activities and life rythms (physical activity, inactivity, sleep) using actimeters (Motion 8), inertial sensors (GaitUP) and questionaires during 14 days :

• Actimetry : evaluation of daily activity and inactivity, sleep rythms
• Inertial sensors : gait evaluation during daily activities
• Questionaires : sleep (Spiegel & St Mary's Hospitral) and fatigue (MFI-20)

Gait evaluation

Intervention Type: BEHAVIORAL

Evaluation of gait characteristics (spatio-temporal parameters & non-linear characteristics) in virtual environment :

• Locomotor simple task : gait only in congruent environment
• Locomotor dual task : gait in similar environment combined with a visually displayed Stroop task
• Sensorimotor gait adaptaition : evaluation of the adaptation capability throughout a split-belt treadmill sequence (realized in simple or dual -combined with the visual Stroop task-)

Neuropsychological evaluation

Intervention Type: BEHAVIORAL

Complete neuropsychological examination including attentional and executive functions, learning and retrieval abilities in episodic memory and general cognitive skills :

• Divided attention (TAP; test of attentional performance)
• California Verbal Learning Test
• The Rey-Osterrieth Complex Figure
• Symbol search and coding (WAIS-IV)
• Go/No-go (TAP)
• Flexibility (TAP)
• Original task of multimodal integration
• Verbal fluencies (GREFEX)

Motoric Cognitive Syndrom

MCR group composed of 80 MCR participants.

MRI evaluation

Intervention Type: PROCEDURE

Multimodal MRI evaluation :

• T1 structural,
• Resting echo planar imaging
• Diffusion-weighted imaging
• Arterial sping labeling
• Fluid-attenuated inversion recovery

Actimetry & IMU

Intervention Type: BEHAVIORAL

Evaluation of daily activities and life rythms (physical activity, inactivity, sleep) using actimeters (Motion 8), inertial sensors (GaitUP) and questionaires during 14 days :

• Actimetry : evaluation of daily activity and inactivity, sleep rythms
• Inertial sensors : gait evaluation during daily activities
• Questionaires : sleep (Spiegel & St Mary's Hospitral) and fatigue (MFI-20)

Gait evaluation

Intervention Type: BEHAVIORAL

Evaluation of gait characteristics (spatio-temporal parameters & non-linear characteristics) in virtual environment :

• Locomotor simple task : gait only in congruent environment
• Locomotor dual task : gait in similar environment combined with a visually displayed Stroop task
• Sensorimotor gait adaptaition : evaluation of the adaptation capability throughout a split-belt treadmill sequence (realized in simple or dual -combined with the visual Stroop task-)

Neuropsychological evaluation

Intervention Type: BEHAVIORAL

Complete neuropsychological examination including attentional and executive functions, learning and retrieval abilities in episodic memory and general cognitive skills :

• Divided attention (TAP; test of attentional performance)
• California Verbal Learning Test
• The Rey-Osterrieth Complex Figure
• Symbol search and coding (WAIS-IV)
• Go/No-go (TAP)
• Flexibility (TAP)
• Original task of multimodal integration
• Verbal fluencies (GREFEX)

Interventions

MRI evaluation

Multimodal MRI evaluation :

• T1 structural,
• Resting echo planar imaging
• Diffusion-weighted imaging
• Arterial sping labeling
• Fluid-attenuated inversion recovery

Intervention Type: PROCEDURE

Actimetry & IMU

Evaluation of daily activities and life rythms (physical activity, inactivity, sleep) using actimeters (Motion 8), inertial sensors (GaitUP) and questionaires during 14 days :

• Actimetry : evaluation of daily activity and inactivity, sleep rythms
• Inertial sensors : gait evaluation during daily activities
• Questionaires : sleep (Spiegel & St Mary's Hospitral) and fatigue (MFI-20)

Intervention Type: BEHAVIORAL

Gait evaluation

Evaluation of gait characteristics (spatio-temporal parameters & non-linear characteristics) in virtual environment :

• Locomotor simple task : gait only in congruent environment
• Locomotor dual task : gait in similar environment combined with a visually displayed Stroop task
• Sensorimotor gait adaptaition : evaluation of the adaptation capability throughout a split-belt treadmill sequence (realized in simple or dual -combined with the visual Stroop task-)

Intervention Type: BEHAVIORAL

Neuropsychological evaluation

Complete neuropsychological examination including attentional and executive functions, learning and retrieval abilities in episodic memory and general cognitive skills :

• Divided attention (TAP; test of attentional performance)
• California Verbal Learning Test
• The Rey-Osterrieth Complex Figure
• Symbol search and coding (WAIS-IV)
• Go/No-go (TAP)
• Flexibility (TAP)
• Original task of multimodal integration
• Verbal fluencies (GREFEX)

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Aged 55-75 years
• Right-handed as assessed by the Edinburgh Inventory
• Health Insurance
• Able to follow experimental instructions
• Consent
• Independent in daily life activities as assessed by Katz autonomy score, ADL and IADL

• Reduced gait speed as assessed by the 4m or 10m walk test value compared to normative values (Bohannon & Williams Andrews, 2011)
• Subjective cognitive complaint as assessed by dedicated questionnaire
• Subnormal cognitive function as assessed by the Montreal Cognitive Assessment (MoCA) test with score > 23

• Subnormal cognitive function as assessed by the Montreal Cognitive Assessment (MoCA) test with score > 23

Exclusion Criteria

• Uncorrected visual or auditive deficits not allowing the realization of the experiment
• Evolutive disease (such as cancer)
• Active depression
• Neurological or psychiatric antecedent
• Neuromuscular impairment
• BMI < 35
• Counter-indication to MRI

• Minimum Eligible Age: 55 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

University Hospital, Caen

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Pierre Denise, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de Caen Normandie

Locations

CHU de Caen Normandie

Caen, , France

Site Status: RECRUITING

Countries

France

Central Contacts

Leslie M. Decker, PhD

Role: CONTACT

leslie.decker@unicaen.fr

06.70.40.58.44 ext. +33

Facility Contacts

Pierre Denise, MD, PhD

Role: primary

Other Identifiers

PRESAGE

Identifier Type: -

Identifier Source: org_study_id